ChengBang Syncore Technology (603316.SH)'s application for issuing shares to specific targets received approval for registration from the CSRC.
ChengBang Syncore Technology (603316.SH) announced that on October 14, 2026, the company received the "Approval Regarding the Registration of ChengBang Syncore Technology Co., Ltd.'s Issuance of Shares to Specific Targets" (CSRC Permit [2026] No. 2759) issued by the China Securities Regulatory Commission, approving the company's registration application for issuing shares to specific targets.
ChengBang Syncore Technology (603316.SH) announced that on October 14, 2026, the company received the "Approval Regarding the Registration of ChengBang Syncore Technology Co., Ltd.'s Issuance of Shares to Specific Targets" (CSRC Permit [2026] No. 2759) issued by the China Securities Regulatory Commission, approving the company's registration application for issuing shares to specific targets.
Related Articles
DAWNRAYS PHARMA (02348) repurchased 4,000 shares for HK$3,840 on October 14.
TUHU-W (09690) repurchased 136,500 shares for approximately HK$1.5641 million on October 14.
KEEP (03650) grants 984,050 restricted share units.
DAWNRAYS PHARMA (02348) repurchased 4,000 shares for HK$3,840 on October 14.
TUHU-W (09690) repurchased 136,500 shares for approximately HK$1.5641 million on October 14.
KEEP (03650) grants 984,050 restricted share units.
